The Single Cell Multiomics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for the single cell multiomics has experienced significant growth recently. The market was valued at $3.97 billion in 2024 and is projected to reach $4.85 billion in 2025, with a compound annual growth rate (CAGR) of 22.1%.
The Single Cell Multiomics Global Market is predicted to reach $10.69 billion in 2029, growing with a compound annual growth rate (CAGR) of 21.8%.
Download Your Free Sample of the 2025 Single Cell Multiomics Market Report and Uncover Key Trends Now!The key drivers in the single cell multiomics market are:
• Growing adoption of precision medicine
• Increasing focus on rare diseases
• Rising interest in stem cell research
• Increasing demand for high throughput screening
The single cell multiomics market covered in this report is segmented –
1) By Type: Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics
2) By Technique: Single Cell Isolation And Dispensing, Single Cell Analysis
3) By Application: Oncology, Cell Biology, Neurology, Immunology, Stem Cell Research
4) By End User: Academic Institutes, Contract Research Organizations, Pharmaceutical And Biotech Companies
Subsegments:
1) By Single Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single Cell DNA Amplification Techniques, Genomic Analysis Platforms
2) By Single Cell Proteomics: Mass Spectrometry-Based Techniques, Protein Microarrays, Enzyme-Linked Immunosorbent Assays (ELISA), Single Cell Protein Analysis Platforms
3) By Single Cell Transcriptomics: Single Cell RNA Sequencing (scRNA-seq), RNA Amplification Techniques, Microfluidics-Based Transcriptomics, Transcriptome Analysis Tools
4) By Single Cell Metabolomics: Mass Spectrometry For Metabolite Analysis, Nuclear Magnetic Resonance (NMR) Techniques, Liquid Chromatography For Metabolomics, Metabolite Profiling Tools
The key trends in the single cell multiomics market are:
• The development of multiparameter profiling tools is a major emerging trend.
• Advances in spatial transcriptomics are significantly shaping the future of the market.
• The adoption of high resolution imaging techniques is an important upcoming trend.
• The utilization of integrated omics databases and the development of advanced bioinformatics solutions are also growing trends.
Major players in the single cell multiomics market are:
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Becton Dickinson and Company
• Illumina Inc.
• BioRad Laboratories Inc.
• QIAGEN N.V.
• BioTechne Corporation
• Miltenyi Biotec BV & Co KG
• BGI Genomics Co Ltd.
• 10x Genomics Inc.
• Molecular Devices LLC
• NanoString Technologies Inc.
• Standard BioTools Inc.
• Akoya Biosciences Inc.
• Takara Bio Inc.
• Synthego Corporation
• Mission Bio Inc.
• DeepCell Inc.
• RareCyte Inc.
• Parse Biosciences Inc.
• Dolomite Bio Ltd.
• Stilla Technologies SAS
• NanoCellect Biomedical Inc.
• Epicypher Inc.
• Scipio Biosciences SAS
North America was the largest region in the single cell multiomics market in 2024